APIMEDS PHARMACEUTICALS US, INC. Stock Issued During Period, Shares, New Issues
APIMEDS PHARMACEUTICALS US, INC. (APUS) had Stock Issued During Period, Shares, New Issues of 251.52 thousand shares as of 2026-05-11, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-08-14
- 2026-05-11: Stock Issued During Period, Shares, New Issues 251.52K shares.
| Period end | Stock Issued During Period, Shares, New Issues |
|---|---|
| 2026-05-11 | 251.52K shares 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |